Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070. (Q39174058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

title

Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

Matthew C. Wright

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

author name string

I Swidenbank

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

H Marshall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

C E Barker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

J Armstrong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

S A White

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

S P Fricker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

R Plummer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

P E Lovat

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

28 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

British Journal of Cancer

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

1634-1640

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

BRAFV600E negatively regulates the AKT pathway in melanoma cell lines

27 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

PLX-4032, a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

CXCL12 (SDF-1)/CXCR4 pathway in cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

CXCR4 in clinical hematology

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Tumour cell survival signalling by the ERK1/2 pathway

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Melanoma biology and new targeted therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Cutaneous melanoma susceptibility and progression genes

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Mutations of the BRAF gene in human cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Overcoming hurdles in developing successful drugs targeting chemokine receptors

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668477

Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23538388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ten years of progress in melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23538388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

IL-8 signal transduction in human neutrophils

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23538388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2013.124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json

27 February 2020

PubMed publication ID

23538388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23538388 AND SRC:MED&resulttype=core&format=json